Literature DB >> 10809849

Clinicopathological features of CD56+ nasal-type T/natural killer cell lymphomas with lobular panniculitis.

S E Chang1, J Huh, J H Choi, K J Sung, K C Moon, J K Koh.   

Abstract

Nasal-type T/natural killer cell lymphoma (TNKCL) shows frequent extranodal involvement including the skin, and is associated with a poor prognosis. We have studied six patients with nasal-type TNKCL presenting with inflammatory subcutaneous nodular lesions with a subcutaneous lymphoid infiltrate. Clinical information was obtained from the medical records of the patients and at follow-up. All cases showed features of angiocentric lymphoma on histology, although there was diffuse cellular infiltration rather than an angiocentric pattern in the subcutis. All six patients were similar in immunophenotype: positive for CD56 and either cytoplasmic CD3 or CD45RO, but negative for B-cell markers and CD30. In situ hybridization using an anti-sense Epstein-Barr virus early regions probe showed a positive reaction in all cases. All patients either died with progressive disease or showed no response to combined chemotherapy. The diagnosis of nasal-type TNKCL, which has a fatal outcome, is facilitated by detection of CD56-positive tumour cells. In evaluating lobular panniculitis including apparently benign inflammatory subcutaneous nodules, nasal-type TNKCL should be considered in the differential diagnosis, especially in Asian countries.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10809849     DOI: 10.1046/j.1365-2133.2000.03472.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  1 in total

1.  CD56-positive haematological neoplasms of the skin: a multicentre study of the Cutaneous Lymphoma Project Group of the European Organisation for Research and Treatment of Cancer.

Authors:  Chalid Assaf; Sylke Gellrich; Sean Whittaker; Alistair Robson; Lorenzo Cerroni; Cesare Massone; Helmut Kerl; Christian Rose; Andreas Chott; Sergio Chimenti; Christian Hallermann; Tony Petrella; Janine Wechsler; Martine Bagot; Michael Hummel; Katrin Bullani-Kerl; Marcel W Bekkenk; Werner Kempf; Chris J L M Meijer; Rein Willemze; Wolfram Sterry
Journal:  J Clin Pathol       Date:  2006-10-03       Impact factor: 3.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.